1. Home
  2. JHX vs ABVX Comparison

JHX vs ABVX Comparison

Compare JHX & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo James Hardie Industries plc (Ireland)

JHX

James Hardie Industries plc (Ireland)

HOLD

Current Price

$21.02

Market Cap

11.4B

Sector

Industrials

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$115.66

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JHX
ABVX
Founded
1888
2013
Country
Ireland
France
Employees
5860
67
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
9.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JHX
ABVX
Price
$21.02
$115.66
Analyst Decision
Strong Buy
Buy
Analyst Count
9
13
Target Price
$27.83
$131.31
AVG Volume (30 Days)
6.6M
756.8K
Earning Date
05-19-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.06
$52.14
Revenue Next Year
$14.50
$4,132.27
P/E Ratio
$122.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.46
$5.59
52 Week High
$29.83
$148.83

Technical Indicators

Market Signals
Indicator
JHX
ABVX
Relative Strength Index (RSI) 50.49 50.30
Support Level $21.08 $107.55
Resistance Level $22.71 $129.84
Average True Range (ATR) 0.88 5.24
MACD 0.03 -0.80
Stochastic Oscillator 46.82 46.55

Price Performance

Historical Comparison
JHX
ABVX

About JHX James Hardie Industries plc (Ireland)

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: